Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein ...

We think its portfolio and pipeline support a wide moat, and with the HCV market stabilizing, Gilead needs strong continued innovation in HIV, solid oncology pipeline data, and smart future ...

Home Remodeling Specialist at MegaPros Home Improvement Jeremy Hogel joins the program to answer a listener’s question pertaining ...

Q3 2025 Earnings Call Transcript February 11, 2025 Orion Energy Systems, Inc. beats earnings expectations. Reported EPS is ...

Sunoco LP (NYSE: SUN) Q4 2024 Earnings Call Transcript February 11, 2025 Sunoco LP misses on earnings expectations. Reported ...

In a culture of continuous innovation, failure should never be seen as the end of the road. Instead, it’s an opportunity to ...

The approval of a plan by the Iraqi Parliament to increase payments to international oil companies operating in the semiautonomous northern region is ...

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...